ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities. The ...
ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities. The ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
In a world that’s moving towards more sustainable energy solutions, a new type of marine engine is creating a buzz ...
The investment objective of the Fund is to replicate the performance of the MSCI Emerging Markets Index (the “Index”), while minimising as far as possible the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results